TNAG-1981-FCO40-2814-UK-Hong-Kong-Scholarship-Scheme-donation-to-the-UK-Governme-1989 — Page 291

FCO40 Hong Kong Department Records 聯邦事務部香港部檔案 All

PJYAEK

Foreign and Commonwealth Office

London SW1A 2AH

G MO Briegel Esq

Legacy Officer

The Institute of Cancer Research

Royal Cancer Hospital 17a Onslow Gardens

LONDON

SW7 3AL

Telephone 01-

270

2653

Your reference

Our reference

HKD 286/1

Mlen 28611 нко

Date

30 January 1989

SIR S K TANG DONATION

FINANCIAL ARRANGEMENTS

о

Thank you for your letter of 23 January, which followed on from our earlier telephone conversation.

The purpose of this letter is to set out the conditions under which the donation to the Institute of Cancer Research will be made. They are as follows:

(a) The donation will be known as the "Sir S K Tang Fund".

(b) The Fund will be for the sole use of the Institute of Cancer Research, in perpetuity from the date of its receipt, who will assume responsibility for its proper administration.

(c) The Fund will consist of a principal sum of £333,333 plus an amount of accrued interest in the region of £97, 949

(d) The principal sum of £333,333 is to be invested in such a way as to guarantee its safety while earning a good acceptable rate of interest.

(e) The interest (accrued and earned) is to be used for whatever cancer research projects the Institute considers appropriate; but the principal sum must never be reduced by any form of expenditure or loan. Without the prior approval of the Hong Kong Department of the Foreign and Commonwealth Office.

(£)

The Fund will be included in the Institute's annual statement of income and expenditure but in no other way is the Fund to attract publicity of any kind

(g) Until otherwise instructed an annual statement of account, covering the Sir S K Tang Fund, is to be sent to the Hong Kong Department of the Foreign and Commonwealth Office.

Comments

Approved members can add comments, bookmarks, and private notes.

No comments yet.

Private Research Note

Private notes are available after approval.